Company profile for Marea Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Marea Therapeutics is a distinguished biotechnology company focused on advancing novel therapies for addressing severe autoimmune diseases. Based on cutting-edge scientific research, Marea Therapeutics is committed to developing innovative treatments that target underlying disease mechanisms, aiming to improve patient outcomes significantly. The company's dedication to scientific excellence and patient-centric innovation drive...
Marea Therapeutics is a distinguished biotechnology company focused on advancing novel therapies for addressing severe autoimmune diseases. Based on cutting-edge scientific research, Marea Therapeutics is committed to developing innovative treatments that target underlying disease mechanisms, aiming to improve patient outcomes significantly. The company's dedication to scientific excellence and patient-centric innovation drives its mission to create transformative therapies that meet unmet medical needs in autoimmune disorders

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
135 Mississippi St San Francisco, CA 94107
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250811862394/en/Marea-Therapeutics-Enrolls-First-Participant-in-Phase-1-Clinical-Study-Evaluating-MAR002-for-Acromegaly

BUSINESSWIRE
12 Aug 2025

https://www.businesswire.com/news/home/20250803630698/en/Marea-Therapeutics-Enrolls-First-Patient-in-Phase-2b-TYDAL-TIMI-78-Clinical-Study-Evaluating-MAR001-in-Adults-at-Risk-of-ASCVD

BUSINESSWIRE
04 Aug 2025

https://www.businesswire.com/news/home/20250713923670/en/Marea-Therapeutics-Presents-Preclinical-Data-on-Novel-Growth-Hormone-Receptor-Antagonist-Antibody-MAR002-for-the-Treatment-of-Acromegaly-at-ENDO-2025

BUSINESSWIRE
14 Jul 2025

https://www.businesswire.com/news/home/20250630861477/en/Marea-Therapeutics-Appoints-Shishir-Gadam-Ph.D.-as-Chief-Technical-Officer

BUSINESSWIRE
01 Jul 2025

https://www.businesswire.com/news/home/20250623891703/en/Marea-Therapeutics-Announces-Oral-Presentation-Related-to-Acromegaly-Program-at-ENDO-2025

BUSINESSWIRE
24 Jun 2025

https://www.businesswire.com/news/home/20250519952961/en/Marea-Therapeutics-Appoints-Charmi-Turner-as-Senior-Vice-President-People-Culture

BUSINESSWIRE
20 May 2025

ABOUT THIS PAGE

Contact Marea Therapeutics and get a quotation

Marea Therapeutics is a supplier offers 7 products (APIs, Excipients or Intermediates).

Find a price of Flunixin Meglumine bulk with CEP offered by Marea Therapeutics

Find a price of Ceftiofur bulk offered by Marea Therapeutics

Find a price of Cephapirin Benzathine bulk offered by Marea Therapeutics

Find a price of Cephapirin Sodium bulk offered by Marea Therapeutics

Find a price of Gamithromycin bulk offered by Marea Therapeutics

Find a price of Nicarbazin bulk offered by Marea Therapeutics

Find a price of Tilmicosin Phosphate bulk offered by Marea Therapeutics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty